Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00290199 · ClinicalTrials.gov registry record · NA
Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture
A NA study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT00290199: Clinical Trial NA study, sponsored by University of Alabama at Birmingham.
NCT00290199 is a NA study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 169 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00290199, a NA study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
In women undergoing labor induction for membrane rupture at or near term, we are investigating the addition of a foley catheter placed in the cervix to standard therapy (oxytocin administration) to decrease the time from the start of the induction to delivery.
Primary Outcome
The outcome measure is the mean in hours of the time from induction to delivery (up to 24 hours)
Interventions
- DEVICE Transcervical Foley catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-05 |
| Phase | NA |
Why NCT00290199 stopped before completion
NCT00290199 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcervical Foley catheter is the first listed.
NCT00290199 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00290199 about?
NCT00290199 is a clinical study titled "Foley Catheter for Labor Induction in Women With Term and Near Term Membrane Rupture". In women undergoing labor induction for membrane rupture at or near term, we are investigating the addition of a foley catheter placed in the cervix to standard therapy (oxytocin administration) to decrease the time from the start of the induction to delivery.
What is the current status of trial NCT00290199?
This trial is currently terminated. It is a NA study. The enrollment target is 169 participants. The study started on 2005-12. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00290199?
The interventions under investigation include: Transcervical Foley catheter (DEVICE).
Who is sponsoring clinical trial NCT00290199?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00290199's enrollment target sits among peer trials
169 619th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia